Skip to main content
A-LevelBiologyImmunity9700/22 · Feb/Mar 2018 · Q217 Marks

The main cause of tuberculosis (TB) in humans is the bacterium Mycobacterium tuberculosis. Most cases of the disease involve the lungs. The bacterium can enter cells and remain inactive in a latent (dormant) state. However, the bacterium can become active to produce symptoms of the disease. In a person with active TB, the pathogen can be present in airborne droplets that are exhaled. Generally, a healthy person who inhales these droplets has effective defence mechanisms in the gas exchange system to prevent infection.

  1. (a)(i)One example of a defence mechanism against pathogens in the gas exchange system involves the action of macrophages. State the location in the body where macrophages have their origin.[1]
  2. (a)(ii)Describe the mode of action of a macrophage.[3]
  3. (a)(iii)It is sometimes possible for M. tuberculosis to survive within macrophages. Suggest one way in which M. tuberculosis may survive within a macrophage.[1]
  4. (b)A healthy person has other defence mechanisms in the gas exchange system to prevent bacteria entering cells. Describe these defence mechanisms and explain how bacteria in inhaled air are prevented from entering cells of the gas exchange system.[3]
  5. (c)In people with a weakened immune system, M. tuberculosis can infect other organs and tissues, such as the kidneys and joints. Suggest how the bacteria may spread from the lungs to other organs.[1]
  6. (d)TB in humans can be caused by another species of bacterium, M. bovis. State the mode of transmission of this pathogen to humans.[1]
  7. (e)The standard treatment for TB continues for six months and initially involves the use of four different antibiotics. If no antibiotic resistance is detected, the treatment is reduced to two of the four antibiotics. The two antibiotics used are rifampicin and isoniazid. Suggest the benefits of beginning the treatment with four different antibiotics.[2]
  8. (f)Table 2.1 shows the number of reported cases of TB and MDR-TB in the South-East Asia region between 2005 and 2014, as published by the World Health Organization (WHO). Table 2.1 year | total number of reported cases of TB | total number of reported cases of MDR-TB ---- | ---------------------------------- | ------------------------------------ 2005 | 1947603 | 68 2006 | 2104673 | 779 2007 | 2202149 | 918 2008 | 2287803 | 1717 2009 | 2328230 | 2560 2010 | 2332779 | 4263 2011 | 2358127 | 6615 2012 | 2331455 | 14957 2013 | 2297033 | 18384 2014 | 2580605 | 17386 State the trends shown in Table 2.1.[2]
  9. (g)TB is a disease of global importance. Discuss the factors influencing the trends shown in Table 2.1.[3]

Mark scheme

Marking points from the official mark scheme (Feb/Mar 2018). The mark or mark type is shown in brackets.

  1. [1] bone marrow ;
  2. [3] max three from: 1 detection / recognition ; e.g. detects (named type of) pathogen recognises, (foreign) antigens / antibodies complexed to antigens has receptors (for antigens) 2 engulfs / envelops, pathogen / bacterium / AW ; A phagocytosis occurs A endocytosis occurs A pseudopodia form 3 forms, vacuole / vesicle / phagosome; ref. to hydrolytic / digestive, enzymes ; 4 ref. to lysosome fusion ; 5 A named examples A hydrolases 6 ref. to antigen presentation; 7 AVP; e.g. (response is) non-specific / innate
  3. [1] any one valid suggestion from: produces inhibitors for / deactivates, lysosomal enzymes ; escapes out of phagosome; forms resistant spore / is resistant to digestive enzymes ; AVP; e.g. suggestion of macrophage malfunction
  4. [3] any three from: 1 production of mucus by, mucous glands / goblet cells ; 2 sticky / AW, mucus or mucus traps, pathogens / bacteria / microorganisms ; 3 mucus acts as a barrier (to prevent entry); 4 mucus increases distance to reach cells ; 5 cilia on ciliated epithelial cells ; A ciliated epithelium 6 cilia, waft / move, mucus / AW ; 7 idea that (contaminated) mucus is moved, away from alveoli / away from lung tissue / towards back of mouth / AW ;
  5. [1] any one suggestion from: blood / plasma / circulatory system ; lymph / lymph system ; within, neutrophils / macrophages / phagocytes ; A white blood cells / leucocytes
  6. [1] any one from: from infected, cows / cattle ; eating contaminated, meat / beef (from infected cattle); drinking, raw / unpasteurised, milk (from infected cows);
  7. [2] any two from: increases chances of, killing / AW, all bacteria; I will kill all bacteria (unqualified) A will kill all bacteria if bacteria are, susceptible / not resistant if bacteria are resistant to one antibiotic, then still susceptible to other antibiotics / AW ; reduces chance of mutations arising / (if bacteria susceptible) mutations unlikely to occur against all antibiotics ; AVP; e.g. antibiotic can be stopped because of side effects idea that more effective because different antibiotics will work on different targets (in the bacteria)
  8. [2] any two from: overall trend for both is increase ; rate of increase in cases of MDR-TB greater than rate of increase in cases of TB / AW / ora ; ref. to fluctuations / detail of fluctuations / periods of decrease ;
  9. [3] any three from: overall increase in TB cases: 1 ref. to problems with people living in, poorly ventilated accommodation / close proximity to each other/AW; 2 vaccination programmes not able to prevent increase / herd immunity insufficient / AW ; decrease/numbers fairly constant: 3 ref. to (some) success of, prevention / treatment programme ; A described examples increase in MDR-TB: 4 people fail to finish course of treatment for normal TB / AW ; 5 ref. to ease of transmission of TB means easy to transmit MDR-TB ; decrease in 2014 for MDR-TB: 6 suggestion for decrease ; e.g. better, surveillance / cooperation, in completion of drug therapy more successful antibiotics used people better educated about preventing spread for either increase in TB cases or increase in MDR-TB: 7 qualified ref. to link between, HIV / HIV/AIDS, and TB ; 8 less money available for, longer drug treatment/vaccination, by, health authorities / governments ; 9 AVP; e.g. balance between new cases and successfully treated cases means problem still exists in prevention ref. to changes in population size ref. to improvements in data collection ref. to immigration

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Immunity, A-Level Biology (syllabus 9700). Structured question, 17 marks.
Source
A-Level Biology, Feb/Mar 2018 Paper 2 Variant 2, question 2.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep